Metastatic Lung Adenocarcinoma Harboring an EGFR-Activating Mutation in a Heart Transplant Recipient

Podobne knjige/članki

• Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
  od: Nishimura, Toshihide, et al.
  Izdano: (2020)
• Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation
  od: Erdogan, Bulent, et al.
  Izdano: (2016)
• Effectiveness of EGFR‐TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR‐RAD51 Fusion
  od: Guan, Yan, et al.
  Izdano: (2019)
• Bevacizumab plus chemotherapy for patients with advanced pulmonary adenocarcinoma harboring EGFR mutations
  od: Chen, R.-L., et al.
  Izdano: (2017)
• Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs
  od: Lin, Jessica J., et al.
  Izdano: (2015)